CERS Q2 2022 Earnings — Cerus Corporation Revenue & Financial Results | Market Cap Arena

CERSCerus Corporation

$358M

Q2 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$41M+30.2% YoY

Gross Profit

$21M51.9% margin

Operating Income

-$7M-16.7% margin

Net Income

-$8M-20.5% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

+9.5%

Cash Flow

Operating Cash Flow

-$345,000

Free Cash Flow

-$423,000

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$216M

Total Liabilities

$140M

Stockholders' Equity

$76M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$41M	$31M	+30.2%
Gross Profit	$21M	$16M	+31.7%
Operating Income	-$7M	-$14M	+52.5%
Net Income	-$8M	-$15M	+45.4%

Revenue Segments

Product

$21M100%

Geographic Segments

North America

$26M62%

Europe Middle East And Africa

$15M36%

Other

$522,0001%